Anti‑breast cancer potential of frullanolide from Grangea maderaspatana plant by inducing apoptosis

  • Authors:
    • Siriphorn Chimplee
    • Potchanapond Graidist
    • Theera Srisawat
    • Suchada Sukrong
    • Rassanee Bissanum
    • Kanyanatt Kanokwiroon
  • View Affiliations

  • Published online on: April 3, 2019     https://doi.org/10.3892/ol.2019.10209
  • Pages: 5283-5291
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Breast cancer is the leading cause of female mortality worldwide. Although there are several modern treatments for breast cancer, there is a high rate of recurrence for the majority of treatments; therefore, the search for effective anticancer agents continues. The present study aimed to investigate the anti‑breast cancer potential of frullanolide, a compound which is isolated and purified from the Grangea maderaspatana plant, for selected human breast cancer cell lines (MCF‑7, MDA‑MB‑468 and MDA‑MB‑231). The MTT assay was used to assess cytotoxic activity in breast cancer cell lines of treatment with frullanolide at 1.25, 2.5, 5.0, 10.0 and 20.0 µg/ml. Additionally, the apoptotic induction ability of frullanolide at various concentrations [0.5x, 1x and 2x half maximal inhibitory concentration (IC50)] was investigated by flow cytometry and western blot analysis. Frullanolide exhibited strong anti‑breast cancer activity against MDA‑MB‑468 (IC50, 8.04±2.69 µg/ml) and weak cytotoxicity against the MCF‑7 (IC50, 10.74±0.86 µg/ml) and MDA‑MB‑231 (IC50, 12.36±0.31 µg/ml) cell lines. The IC50 of frullanolide was high in the human normal epithelial breast cell line (MCF‑12A) and mouse fibroblast cell line (L‑929). Density plot diagrams revealed that frullanolide induced apoptosis in MCF‑7, MDA‑MB‑468 and MDA‑MB‑231 cells. Notably, a plausible anticancer mechanism was elucidated via cellular apoptosis by p53‑independence in the treated MCF‑7 cell line and p53‑dependence in the treated MDA‑MB‑468 and MDA‑MB‑231 cell lines. In conclusion, the present study demonstrated that frullanolide may exert anticancer activity on breast cancer cell lines by inducing apoptosis. Frullanolide offers a possible novel approach to breast cancer therapy.

References

1 

Stewart BW and Wild CP: World cancer Report 2014 Lyon. International Agency for Research on Cancer (IARC). pp16–53. 2014.

2 

Srisawat T, Sukpondma Y, Chimplee S, Kanokwiroon K, Tedasen A and Graidist P: Extracts from vatica diospyroides type SS fruit show low dose activity against MDA-MB-468 breast cancer cell line via apoptotic action. Biomed Res Int. 2014:4796022014. View Article : Google Scholar : PubMed/NCBI

3 

Noble RL: The discovery of the vinca alkaloids-chemotherapeutic agents against cancer. Biochem Cell Bio. 68:1344–1351. 1990. View Article : Google Scholar

4 

Kumar A, Patil D, Rajamohanan PR and Ahmad A: Isolation, purification and characterization of vinblastine and vincristine from endophytic fungus Fusarium oxysporum isolated from Catharanthus roseus. PLoS One. 8:e718052013. View Article : Google Scholar : PubMed/NCBI

5 

Patel V, Shukla S and Patel S: Free radical scavenging activity of Grangea maderaspatana Poir. Pharmacogn Mag. 5:381–387. 2009. View Article : Google Scholar

6 

Rao VM, Damu GLV, Sudhakar D and Rao CV: Two new bio-active flavones from Grangea maderaspatana (Artemisia maderaspatana). Asian J Chem. 21:1552–1558. 2009.

7 

Chaturvedi D: Sesquiterpene lactones: Structural diversity and their biological activities. In: Tiwari VK and Mishra BB (eds.): Opportunity, Challenge and Scope of Natural Products in Medicinal Chemistry. Research Signpost. (Kerala, India). 313–334. 2011.

8 

Ahmed M, Islam MM, Hossain CF and Khan OF: A preliminary study on the analgesic activity of Grangea maderaspatana. Fitoterapia. 72:553–554. 2011. View Article : Google Scholar

9 

Ruangrungsi N, Kasiwong S and Likhitwitayawuid K: Constituents of Grangea maderaspatana a new Eudesmanolide. J Nat Prod. 52:130–134. 1989. View Article : Google Scholar

10 

Sangmalee S, Laorpaksa A and Sukrong S: A topoisomerase II poison screen of ethnomedicinal Thai plants using a yeast cell-based assay. J Ethnopharmacol. 142:432–437. 2012. View Article : Google Scholar : PubMed/NCBI

11 

Singh D, Mathela CS, Pande V and Panwar A: Antioxidant and antimicrobial activity of Grangea maderaspatana (L.) Poir. Extract. JDDT. 1:46–52. 2013.

12 

Uppatanpreecha P: Topoisomerase I inhibitory activity from Thai medicinal plants in yeast cell-based assay. Dissertation. (Bangkok, Chulalongkorn University). 2009.

13 

Ghantous A, Gali-Muhtasib H, Vuorela H, Saliba NA and Darwiche N: What made sesquiterpene lactones reach cancer clinical trials? Drug Discov Today. 15:668–678. 2010. View Article : Google Scholar : PubMed/NCBI

14 

Srisawat T, Chumkaew P, Heed-Chim W, Sukpondma Y and Kanokwiroon K: Phytochemical screening and cytotoxicity of crude extracts of Vatica diospyroides Symington type LS. Trop J Pharm Res. 12:71–76. 2013.

15 

Alitheen NB, Mashitoh AR, Yeap SK, Shuhaimi M, Manaf AA and Nordin L: Cytotoxic effect of damnacanthal, nordamnacanthal, zerumbone and betulinic acid isolated from Malaysian plant sources. Int Food Res J. 17:711–719. 2010.

16 

Wibowo A, Ahmat N, Hamzah AS, Sufian AS, Ismail NH, Ahmad R, Jaafar FM and Takayama H: Malaysianol A, a new trimer resveratrol oligomer from the stem bark of Dryobalanops aromatica. Fitoterapia. 82:676–681. 2011. View Article : Google Scholar : PubMed/NCBI

17 

Bézivin C, Tomasi S, Lohézic-Le Dévéhat F and Boustie J: Cytotoxic activity of some lichen extracts on murine and human cancer cell lines. Phytomedicine. 10:499–503. 2003. View Article : Google Scholar : PubMed/NCBI

18 

Chadwick M, Trewin H, Gawthrop F and Wagstaff CF: Sesquiterpenoid lactones: Benefits to plants and people. Int J Mol Sci. 14:12780–12805. 2013. View Article : Google Scholar : PubMed/NCBI

19 

Kreuger MR, Grootjans S, Biavatti MW, Vandenabeele P and D'Herde K: Sesquiterpene lactones as drugs with multiple targets in cancer treatment: Focus on parthenolide. Anticancer Drugs. 23:883–896. 2012.PubMed/NCBI

20 

Matejić J, Šarac Z and Ranđelović V: Pharmacological activity of sesquiterpene lactones. Biotechnol Biotechnol Equip. 24 (Suppl 1):S95–S100. 2010. View Article : Google Scholar

21 

Cordell GA, Kinghorn D and Pezzuto JM: Separation, structure elucidation, and bioassay of cytotoxic natural products. Colegate SM and Molyneux RJ: Bioactive natural products, Boca raton, CRC press. 195–216. 1993.

22 

Wu C, Chen F, Rushing JW, Wang X, Kim HJ, Huang G, Haley-Zitlin V and He G: Antiproliferative activities of parthenolide and golden feverfew extract against three human cancer cell lines. J Med Food. 9:55–61. 2006. View Article : Google Scholar : PubMed/NCBI

23 

van Haaften C, Duke CC, Weerheim AM, Smit NP, van Haard PM, Darroudi F and Trimbos BJ: Potent cytotoxic effects of Calomeria amaranthoides on ovarian cancers. J Exp Clin Cancer Res. 30:1–6. 2011. View Article : Google Scholar : PubMed/NCBI

24 

Fischedick JT, Pesic M, Podolski-Renic A, Bankovicc J, de Vosd RCH, Perić M, Todorovićg S and Tanicc N: Cytotoxic activity of sesquiterpene lactones from Inula britannica on human cancer cell lines. Phytochem Lett. 6:246–252. 2012. View Article : Google Scholar

25 

Kabeer FA, Sreedevi GB, Nair MS, Rajalekshmi DS, Gopalakrishnan LP, Kunjuraman S and Prathapan R: Antineoplastic effects of deoxyelephantopin, a sesquiterpene lactone from Elephantopus scaber, on lung adenocarcinoma (A549) cells. J Integr Med. 11:269–277. 2013. View Article : Google Scholar : PubMed/NCBI

26 

Costantino VV, Mansilla SF, Speroni J, Amaya C, Cuello-Carrión D, Ciocca DR, Priestap HA, Barbieri MA, Gottifredi V and Lopez LA: The sesquiterpene lactone dehydroleucodine triggers senescence and apoptosis in association with accumulation of DNA damage markers. PLoS One. 8:e531682013. View Article : Google Scholar : PubMed/NCBI

27 

Maldonado EM, Svensson D, Oredsson SM and Sterner O: Cytotoxic sesquiterpene lactones from Kauna lasiophthalma Griseb. Sci Pharm. 82:147–160. 2014. View Article : Google Scholar : PubMed/NCBI

28 

Babaeia G, Aliarab A, Abroon S, Rasmi Y and Gholizadeh-Ghaleh Aziz S: Application of sesquiterpene lactone: A new promising way for cancer therapy based on anticancer activity. Biomed Pharmacother. 106:239–246. 2018. View Article : Google Scholar : PubMed/NCBI

29 

Ma G, Chong L, Li Z, Cheung AH and Tattersall MH: Anticancer activities of sesquiterpene lactones from Cyathocline purpurea in vitro. Cancer Chemother Pharmacol. 64:143-152. 2009. View Article : Google Scholar : PubMed/NCBI

30 

Li Y, Ni ZY, Zhuc MC, Dong M, Wang SW, Shi QW, Zhang ML, Wang YF, Huo CH, Kiyota H and Cong B: Antitumour activities of sesquiterpene lactones from Inula helenium and Inula japonica. Z Naturforsch C. 67:375–380. 2012. View Article : Google Scholar : PubMed/NCBI

31 

Mahmoud AA, AlFredan MA and El-Sayed WM: Isolation, characterization and anticancer activity of seven compounds from the aerial parts of Conyza triloba. Int J Pharmacognosy and Phytochem Res. 8:2071–2079. 2016.

32 

Rosselli S, Bruno M, Raimondo FM, Spadaro V, Varol M, Koparal AT and Maggio A: Cytotoxic effect of eudesmanolides isolated from flowers of Tanacetum vulgare ssp. Siculum. Molecules. 17:8186–8195. 2012. View Article : Google Scholar : PubMed/NCBI

33 

Rivero A, Quintana J, Eiroa JL, Lo´pez M, Triana J, Bermejo J and Este´vez F: Potent induction of apoptosis by germacranolide sesquiterpene lactones on human myeloid leukemia cells. Eur J Pharmacol. 482:77–84. 2003. View Article : Google Scholar : PubMed/NCBI

34 

Wang Y, Wang Y, Wu AA, Zhang L, Hu Z, Huang H, Xu Q and Deng X: New 12,8-eudesmanolides from Eutypella sp. 1–15. J Antibiot (Tokyo). 70:1029–1032. 2017. View Article : Google Scholar : PubMed/NCBI

35 

Holliday DL and Speirs V: Choosing the right cell line for breast cancer research. Breast Cancer Res. 13:2152011. View Article : Google Scholar : PubMed/NCBI

36 

Hudisa CA and Gianni L: Triple-negative breast cancer: An unmet medical need. Oncologist. 16 (Suppl 1):S1–S11. 2011. View Article : Google Scholar

37 

Kandula M, Ch KK and Ys AR: Molecular mechanism and targeted therapy options of triple-negative (ER, PgR, HER−2/neu) breast cancer: Review. World J Oncol. 4:137–141. 2013.PubMed/NCBI

38 

Sawatdichaikul O, Hannongbua S, Sangma C, Wolschann P and Choowongkomon K: In silico screening of epidermal growth factor receptor (EGFR) in the tyrosine kinase domain through a medicinal plant compound database. J Mol Model. 18:1241–1254. 2012. View Article : Google Scholar : PubMed/NCBI

39 

Qin JJ, Wang W, Voruganti S, Wang H, Zhang WD and Zhang R: Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation. Oncotarget. 6:2623–2640. 2015. View Article : Google Scholar : PubMed/NCBI

40 

Niculescu III AB, Chen X, Smeets M, Hengst L, Prives C and Reed SI: Effects of p21Cip1/Waf1 at both the G1/S and the G2/M cell cycle transitions: pRb ss a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol. 18:629–643. 1998. View Article : Google Scholar : PubMed/NCBI

41 

Gartel ALand Tyner AL: The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther. 8:639–649. 2002.

42 

Moll UM and Petrenko O: The MDM2-p53 interaction. Mol Cancer Res. 1:1001–1008. 2003.PubMed/NCBI

43 

Tsvetkov P, Reuven N and Shaul Y: Ubiquitin-independent p53 proteasomal degradation. Cell Death Differ. 17:103–108. 2010. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

June 2019
Volume 17 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Chimplee, S., Graidist, P., Srisawat, T., Sukrong, S., Bissanum, R., & Kanokwiroon, K. (2019). Anti‑breast cancer potential of frullanolide from Grangea maderaspatana plant by inducing apoptosis . Oncology Letters, 17, 5283-5291. https://doi.org/10.3892/ol.2019.10209
MLA
Chimplee, S., Graidist, P., Srisawat, T., Sukrong, S., Bissanum, R., Kanokwiroon, K."Anti‑breast cancer potential of frullanolide from Grangea maderaspatana plant by inducing apoptosis ". Oncology Letters 17.6 (2019): 5283-5291.
Chicago
Chimplee, S., Graidist, P., Srisawat, T., Sukrong, S., Bissanum, R., Kanokwiroon, K."Anti‑breast cancer potential of frullanolide from Grangea maderaspatana plant by inducing apoptosis ". Oncology Letters 17, no. 6 (2019): 5283-5291. https://doi.org/10.3892/ol.2019.10209